Delivery Order SPE2DB22D3301-SPE2DB25FY9CB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta 75 mg tablets (100 count) with a ceiling value of $1,432.38. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) on August 5, 2025, with completion targeted for August 6, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta 75 mg tablets (100 count) valued at $1,432.38 under a firm fixed price contract. The award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,070.28 to AmerisourceBergen Drug Corp for Nucynta Tabs 100mg, a prescription pain management medication. This competitively awarded, firm fixed-price contract was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) valued at $4,050.39. This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nucynta ER 100 mg tablets (60-count packages) valued at $1,975.65. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among qualified...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9CBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,849.76 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta 100 mg tablets (100-count). The contract reflects a firm fixed-price arrangement with an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside delivery order was competitively awarded and represents a routine pharmaceutical procurement within DLA's medical supply operations. AmerisourceBergen Drug Corp executes this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the federal government, AmerisourceBergen maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting military healthcare systems, the Defense Health Agency, and other federal customers. This delivery order for pain management medication aligns with the company's established role as a critical pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/8/25 |